Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (2410)	2/19/1998 9:45:00 AM
From: Brander	Read Replies (1) \| Respond to of 7041

Linda, I would prefer to wait until I see the report myself before I say their phase III trials are a failure. I am not ready to write ZONA off yet. My interpretation of the data that I have seen to date is that their is potential for phentolamine. From the brief snipits of information posted on these thread about the drop outs, etc, I can't conclude yet that the trial is a failure. The sky has not fallen at this point.